Clinical trials
Observational Sandhoff Disease trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Azafaros B.V. | 1 |
| Idorsia Pharmaceuticals Ltd. | 1 |
| SphinCS Lyso Gemeinnutzige UG (Haftungsbeschrankt) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gangliosidoses, GM2 | 3 |
| Gangliosidosis, GM1 | 3 |
| Sandhoff Disease | 3 |
| Tay-Sachs Disease | 3 |
| Tay-Sachs Disease, AB Variant | 2 |
| Gangliosidoses | 1 |
| Gaucher Disease | 1 |
| Genetic Diseases, Inborn | 1 |
| Lysosomal Storage Diseases | 1 |
| Mucolipidoses | 1 |
Trials
Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.